News & Events
Progressive MS Alliance expands
The Alliance has been joined by four MS International Federation member organisations
Universal access declaration reaches 88,000 signatures
The MS International Federation encourages everyone affected by MS to sign the declaration
Underweight women on fingolimod at higher risk of lymphopenia
Underweight women and patients with low baseline lymphocyte counts should be monitored more closely
Using spectroscopy to recognize secondary-progressive MS patients
A new way to predict the transition from relapsing-remitting to secondary-progressive MS
Cognitive rehabilitation in MS
Computer-aided cognitive rehabilitation can slow down cognitive impairment in MS patients
Avoiding post-partum MS worsening
French study supports the idea of avoiding delays after pregnancy before starting natalizumab therapy
Trigeminal neuralgia and fampridine: further contraindication
Fampridine must be used with caution in people with a history of MS-related trigeminal neuralgia
New treatment for fatigue
Researchers find that Alfacalcidol is a safe and effective treatment for fatigue
Phase one of European Register for MS completed
The register aims to address the recognised lack of relevant MS data at European level
Treat Me Right campaign changes UK guidelines
The UK MS Society’s campaign calls for the right treatment at the right time
Middle East volunteers trained in MS counselling
Volunteers from MS organisations in Lebanon, Egypt and Jordan took part in a three-day training course
2014 McDonald Fellowships announced
This year’s McDonald Fellowships went to researchers from Bangladesh, Hungary, Iran and Yemen